Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome

NCT02057692 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Alagille Syndrome

Interventions

DRUG: LUM001
DRUG: Placebo

Sponsor

Mirum Pharmaceuticals, Inc.

Collaborators

[object Object]